Monday, September 30, 2013

A Strong Third-Quarter Rebound for Canada’s Economy?

Print Friendly

Canada’s latest manufacturing data could portend a strong third quarter for the economy, after last quarter’s gross domestic product (GDP) growth was undermined by historic flooding in Alberta and a province-wide strike in Quebec.

According to Statistics Canada, manufacturing sales climbed 1.7 percent month over month in July, to CAD49.5 billion, a solid rebound following June’s initial decline of 0.5 percent, which was subsequently revised to a decline of just 0.1 percent.

Sales growth was widespread, with gains across 15 of Canada’s 21 industries. Sales of durable goods rose 2.1 percent, to CAD24.8 billion, while sales of non-durable goods increased 1.2 percent, to CAD24.6 billion. Sales of motor vehicles, wood, fabricated metal, and non-metallic mineral products were important growth drivers, while sales in the aerospace sector detracted from growth.

July’s result trounced economists’ consensus forecast, which according to Bloomberg called for a more modest gain of 0.5 percent. Over the past five years, manufacturing sales have declined an average of 0.02 percent per month, while over the past year they’ve increased by an average of 0.04 percent per month. During the nearly five-year period preceding the 2008-09 global downturn, by contrast, factory sales grew an average of 0.3 percent per month.

As such, the July number is significant, though in reviewing data over the past year, February was the single best month for the manufacturing sector, when sales grew 3.4 percent month over month. Month-to-month data tend to be volatile, however, so that didn’t stop manufacturing sales from posting declines in three of the four months thereafter.

This time around, some of the demand that would have ordinarily occurred in the second quarter, absent the aforementioned one-time events, was probably pushed back to the third quarter. That’s evidenced by the dismal number for June GDP, which dropped five-tenths of a percentage point from the previous month, for year-over-year growth of just 0.9 percent.

As a result, economic growth decelerated during the second quarter to a rate of 1.7 percent annualized from 2.5 percent in the prior quarter. But in addition to deferred demand, the third quarter should also get a boost from rebuilding activity following Alberta’s floods.

On that front, we’re still awaiting the Bank of Canada’s (BoC) next set of economic forecasts, which are scheduled to be published in late October. The BoC’s July projections, which came out before second-quarter GDP numbers were announced, showed an ultra-conservative forecast for last quarter of just 1 percent growth. Meanwhile, the central bank forecast growth for the third quarter of 3.8 percent.

Given that growth for the second quarter actually came in at 1.7 percent, it’s likely that the BoC modeled a stronger dampening effect on the second quarter than actually transpired, with more demand pushed back to the third quarter. As a result, the bank will likely lower its third-quarter projection in its next report on monetary policy. For instance, the Royal Bank of Canada is currently forecasting third-quarter GDP growth of 3.4 percent, four-tenths of a percentage point below the BoC’s July estimate.

One of the major headwinds for Canada’s manufacturing sector has been weak demand from the US, which is the country’s largest trading partner. If the nascent US recovery continues to strengthen, then that should bolster the economy of its neighbor to the north. Indeed, the BoC is hoping that the Canadian economy will transition toward export growth, which will, in turn, spur greater business investment.

Top 5 Stocks To Own Right Now

To that end, Canada’s declining currency should help its exports become more competitive in the global market. The loonie traded above parity with the US dollar for much of the two-year period from 2011-12, but then dropped below this key threshold earlier this year in mid-February. The Canadian dollar fell as low as USD0.945 in early July, but currently trades near USD0.97, down about 5.8 percent from its trailing-year high.

While this latest snapshot of the manufacturing sector is just one piece of economic data, at the very least, it comports with economists’ narrative of a third-quarter rebound for Canada’s economy.

Sunday, September 29, 2013

Hot Heal Care Stocks To Buy Right Now

Each week, I endeavor to report the results of the Big Idea Portfolio, a collection of five tech stocks that I believe will crush the market over a three-year period. I've done it before; my last tussle with Mr. Market ended with me beating the index's average return by 13.35%.

Real money was on the line then as it is now, which means any one of the five stocks you see below could tip the scales in my favor. This time, salesforce.com (NYSE: CRM  ) stock sunk 5% Friday after offering subpar guidance the night before.

Wall Street was looking for $0.12 a share in fiscal Q2 earnings on $934.5 million in revenue. Management offered a more conservative target, guiding to $0.11 to $0.12 on $931 to $936 million in revenue. Salesforce stock sold off as a result, but not by as much as I would have expected, given the number of short sellers piling in recently.

Hot Heal Care Stocks To Buy Right Now: Century Aluminum Company(CENX)

Century Aluminum Company, through its subsidiaries, produces primary aluminum in the United States, China, and Iceland. The company offers high purity primary aluminum, molten aluminum, standard-grade ingots, extrusion billets, and other value-added primary aluminum products. It also holds a 40% joint venture interest in a carbon anode and cathode facility located in the Guangxi Zhuang Autonomous Region of south China. The company was founded in 1981 and is headquartered in Monterey, California.

Advisors' Opinion:
  • [By Pendulum]

    Amid the challenges in the aluminum industry, Century Aluminum (CENX) has taken positive actions over the last few months. In June, it acquired the Sebree smelter in Kentucky. More importantly, it received approval for a new power contract at its Hawesville facility, which will improve its cost structure, and the company has similar plans for the new Sebree facility. These actions are reducing the company's cost of production and putting it in a better position to manage through the tough part of the aluminum price cycle. As a result of these actions, Century Aluminum's stock price has outperformed its peers. In this article, I will analyze the challenges in the aluminum industry and the positive impact of Century Aluminum's recent actions.

Hot Heal Care Stocks To Buy Right Now: El En(ELN.MI)

El.En S.p.A., through its subsidiaries, engages in the research, development, manufacture, distribution, and sale of laser systems in Europe and internationally. It offers laser systems for medical applications, including aesthetics, surgical, physiotherapy, dermatology, surgery, cosmetics, dentistry, and gynaecology. The company also provides laser systems for industrial applications, such as cutting, marking, and welding of metals, wood, plastic, and glass, as well as in the decoration of leather and fabric, and the conservative restoration of works of art; and systems for scientific applications and research. In addition, it offers after-sales service, including support for the installation and maintenance of its laser systems; and spare parts, consumables, and technical assistance services. The company sells its products through its subsidiaries, as well as through a network of distributors. El.En S.p.A. was founded in 1981 and is headquartered in Calenzano, Italy.

Top 10 Gold Companies To Watch For 2014: RF Micro Devices Inc.(RFMD)

RF Micro Devices, Inc. designs, develops, manufactures, and markets radio frequency (RF) components and compound semiconductor technologies in the United States and internationally. Its products enable mobility, as well as provide connectivity and support functionality in the cellular handsets, wireless infrastructure, wireless local area networks, cable television /broadband, Smart Energy/advanced metering infrastructure, and aerospace and defense markets. The company offers products that range from single-function components to highly integrated circuits and multi-chip modules (MCMs). Its integrated circuit products include gain blocks, low noise amplifiers, power amplifiers (PAs), receivers, transmitters, transceivers, modulators, demodulators, attenuators, switches, frequency synthesizers, and voltage-controlled oscillators (VCOs); MCM products consist of PA modules, switch-filter modules, active antenna products, VCOs, phase-locked loops, coaxial resonator oscillators , active mixers, variable gain amplifiers, hybrid amplifiers, power doublers, and optical receivers; and passive components consist of splitters, couplers, mixers, and transformers, as well as isolators and circulators. The company markets its products to original equipment manufacturers and original design manufacturers. RF Micro Devices, Inc. was founded in 1991 and is headquartered in Greensboro, North Carolina.

Hot Heal Care Stocks To Buy Right Now: Insteel Industries Inc.(IIIN)

Insteel Industries, Inc. manufactures and markets steel wire reinforcing products for concrete construction applications. The company offers pre-stressed concrete strand (PC strand) and welded wire reinforcement (WWR) products. Its PC strand is a high strength seven-wire strand that is used to impart compression forces into precast concrete elements and structures, which may be either pre-tensioned or post-tensioned, providing reinforcement for bridges, parking decks, buildings, and other concrete structures. The company?s WWR is produced as either a standard or a specially engineered reinforcing product for use in nonresidential and residential construction. Its products comprise concrete pipe reinforcement, an engineered made-to-order product that is used as the primary reinforcement in concrete pipe, box culverts, and precast manholes for drainage and sewage systems, water treatment facilities, and other related applications; engineered structural mesh, an engineered m ade-to-order product, which is used as the primary reinforcement for concrete elements or structures; and standard welded wire reinforcement, a secondary reinforcing product for crack control applications in residential and light nonresidential construction, including driveways, sidewalks, and various slab-on-grade applications. Insteel Industries sells its products through sales representatives to the manufacturers of concrete products, distributors, and rebar fabricators in the United States, Canada, Mexico, and Central and South America. The company was founded in 1958 and is headquartered in Mount Airy, North Carolina.

Hot Heal Care Stocks To Buy Right Now: Guthrie Gts Ltd (G33.SI)

Guthrie GTS Limited, an investment holding company, engages in property, engineering, and leisure businesses in Singapore, Indonesia, and internationally. The company operates through three segments: Property, Engineering, and Leisure. The Property segment engages in the investment, development, and management of retail, commercial, and residential properties; and project management, as well as retail planning, consultancy, marketing, leasing, and mall management. The Engineering segment is involved in undertaking engineering contracts, and trading related products; and the provision of professional services to the transport, telecommunications, air-conditioning, electrical, and fire protection, as well as building and facility management sectors. The Leisure segment invests in, and operates hotels and a golf resort, which comprise the Mercure Vientiane hotel in Laos, the Pullman Jakarta Indonesia hotel in Jakarta, the Novotel Bali Benoa hotel in Bali, and the Indah Puri G olf Resort in Batam. It also offers warehousing facilities; and marketing services to golf clubs and hotels. The company was formerly known as Mulpha (Singapore) Ltd. and changed its name to Guthrie GTS Limited in 1988. Guthrie GTS Limited was founded in 1821 and is headquartered in Singapore.

Hot Heal Care Stocks To Buy Right Now: First Defiance Financial Corp.(FDEF)

First Defiance Financial Corp. operates as the holding company for First Federal Bank of the Midwest that provides financial services to communities based in northwest Ohio, northeast Indiana, and southeastern Michigan. The company offers various deposit products, such as checking accounts, money market accounts, regular savings accounts, term certificate accounts, non-interest-bearing demand deposits, interest bearing demand deposits, time deposits, and certificates of deposit. It also provides residential real estate, non-residential real estate, construction, commercial, home equity and improvement, mobile home, and consumer loans. In addition, the company offers depository, trust, and wealth management services, as well as online banking services. Additionally, First Defiance Financial Corp., through its other subsidiary, First Insurance & Investments, Inc., operates as an insurance agency that offers property and casualty insurance, life insurance, and group health in surance products in the Defiance, Archbold, Bryan, and Bowling Green areas in Ohio. It operates 33 full service branches in northwest Ohio; southeast Michigan; and northeast Indiana. The company was founded in 1935 and is headquartered in Defiance, Ohio.

Hot Heal Care Stocks To Buy Right Now: Poh Tiong Choon Logistics Ltd (P01.SI)

Poh Tiong Choon Logistics Limited, together with its subsidiaries, provides logistics services in Singapore. It offers transportation services for high value, sensitive, and chemical cargoes in conventional, container, bulk, bulk liquid container, and heavy haulage forms through a fleet of refrigerated trucks, tipper trucks, cement tankers, and lorries; and bulk cargo handling and stevedoring services, including loading onto and discharging from vessels various types of cargoes, such as sugar, bulk cement, silica sand, salt, fertilizer, and chemical raw materials. The company also provides warehousing, drumming, and related services consisting of drum filling of chemical products, open and covered warehouse storage, cold room storage, inventory management, and local and international freight management, as well as the storage and distribution of loaded containers; engages in the trade of diesel; and rents industrial property. In addition, it is involved in leasing investme nt properties, as well as in equipment rental business. Further, Poh Tiong Choon Logistics Limited offers terminal management services. The company, formerly known as Poh Tiong Choon Contractors(Pte) Ltd, was founded in 1950 and is based in Singapore.

Hot Heal Care Stocks To Buy Right Now: Scana Corporation(SCG)

SCANA Corporation and its subsidiaries engage in the generation, transmission, distribution, and sale of electricity to retail and wholesale customers in South Carolina. It owns nuclear, coal, hydro, oil and gas, and biomass generating facilities. The company also purchases, sells, and transports natural gas; offers energy-related risk management services; acquires, owns, and provides financing for nuclear fuel, fossil fuel, and emission allowances; and offers service contracts on home appliances, and heating and air conditioning units. In addition, SCANA Corporation owns two liquefied natural gas plants, including one located near Charleston, and the other in Salley, South Carolina; and provides tower site construction, management, and rental services in South Carolina and North Carolina. As of December 31, 2010, the company supplied electricity to approximately 660,000 customers; and natural gas to approximately 482,000 residential, commercial, and industrial customers i n North Carolina, and 313,500 customers in South Carolina, as well as to approximately 460,000 customers in Georgia. Further, SCANA Corporation owns and operates a 500-mile fiber optic telecommunications network and Ethernet network, and data center facilities in South Carolina. Through a joint venture, it builds, manages, and leases communications towers with interest in 2,280 miles of fiber in South Carolina, North Carolina, and Georgia. The company?s retail customers comprise municipalities, electric cooperatives, other investor-owned utilities, registered marketers, and federal and state electric agencies. It primarily serves chemicals, educational services, paper products, food products, lumber and wood products, health services, textile manufacturing, rubber and miscellaneous plastic products, and fabricated metal products industries. The company is based in Cayce, South Carolina.

Advisors' Opinion:
  • [By Chuck Carnevale]

    SCANA Corp (SCG): A Low Growth Regulated Utility

    Our first example plots SCANA Corp. whose earnings growth rate has averaged only 3.3% per annum. Here, we would like to remind the reader that our position is that fair valuation is a function of the earnings yield that ��urrent earnings��represent. Consequently, purchasing a company at fair valuation implies that the investor is making a sound financial decision. However, as previously stated, this does not necessarily guarantee a high future rate of return. As we will illustrate in Part 2, that will be determined by the company�� future earnings growth rate.

Saturday, September 28, 2013

Top 5 Companies To Buy Right Now

As per recent reports from Gartner and IDC, global shipments of personal computers have taken a hit. An 11.0% dip in PC shipments was noticed during the April ��June quarter, as people gradually move away from PCs to handheld tablets and other mobile devices.

The industry research firm, Gartner, is of the opinion that the PC industry is going through the most difficult time as this is the fifth consecutive quarter of decline.

PC makers such as Hewlett-Packard Company (HPQ) and Dell Inc. (DELL) have incurred heavy losses in their PC business. This unprecedented decline resulted in Hewlett-Packard losing ground to Lenovo in the last quarter.

Another major reason for the decline in PC sales is related to the cost of the devices. In the emerging markets, consumers are opting for relatively inexpensive mobile computing devices such as tablets at the entry level.

Top 5 Companies To Buy Right Now: Bridgeline Digital Inc.(BLIN)

Bridgeline Digital, Inc. engages in the development of Web experience management (WEM) product and interactive technology solutions that help organizations to optimize business processes. Its iAPPS product suite includes iAPPS Content Manager that allows non-technical users to create, edit, and publish content through a browser-based interface; iAPPS Commerce, an online B2B and B2C eCommerce solution, which allows users to maximize and manage various aspects of commerce initiatives; and iAPPS Marketier, a marketing lifecycle management solution that comprises customer transaction analysis, email management, surveys and polls, event registration, and issue tracking to measure campaign return on investment and client satisfaction. The company also provides iAPPS Analyzer to manage, measure, and optimize Web properties by recording detailed events and mine data within a Web application for statistical analysis; and iAPPS Rapid Site for building custom Websites. It delivers it s iAPPS product suite through cloud-based software as a service business model or via a traditional perpetual licensing business model. The company?s end-to-end interactive technology solutions consist of digital strategy, user-centered design, Web application development, SharePoint development, rich media development, search engine optimization, and Web application hosting management. Bridgeline Digital serves various markets, such as financial services, consumer products and goods, health services and life sciences, high technology (software and hardware), retail brand names, transportation and storage, associations and foundations, and the U.S. Government through its direct sales force. The company was formerly known as Bridgeline Software, Inc. and changed its name to Bridgeline Digital, Inc. in March 2010. Bridgeline Digital, Inc. was founded in 2000 and is based in Burlington, Massachusetts.

Top 5 Companies To Buy Right Now: (BAJAJ-AUT.NS)

Bajaj Auto Limited manufactures and sells scooters, motorcycles, and three wheeler vehicles and spare parts in India and internationally. It sells its two wheeler products under Avenger, Pulsar, Discover, Platina, and Ninja brands. The company also provides three wheeler commercial vehicles, such as goods and passenger carriers. It sells its products and services through a network of two-wheeler and three-wheeler dealers. The company was founded in 1945 and is headquartered in Pune, India. Bajaj Auto Limited operates independently of Bajaj Holdings & Investment Limited as of May 28, 2008.

Top 10 Gold Companies To Invest In 2014: State Street Corporation(STT)

State Street Corporation, a financial holding company, provides various financial products and services to institutional investors worldwide. The company?s Investment Servicing business line provides products and services, including custody, product- and participant-level accounting; daily pricing and administration; master trust and master custody; record-keeping; foreign exchange, brokerage, and other trading services; securities finance; deposit and short-term investment facilities; loan and lease financing; investment manager and alternative investment manager operations outsourcing; and performance, risk, and compliance analytics. This segment also offers shareholder services, which comprise mutual fund and collective investment fund shareholder accounting. Its Investment Management business line provides a range of investment management, investment research, and other related services, such as securities finance; and strategies for managing passive and active financ ial assets, such as enhanced indexing and hedge fund strategies for U.S. and global equities and fixed-income securities. The company serves mutual funds, collective investment funds and other investment pools, corporate and public retirement plans, insurance companies, foundations, endowments, and investment managers. State Street Corporation was founded in 1832 and is headquartered in Boston, Massachusetts.

Advisors' Opinion:
  • [By Holly LaFon]

    In the fourth quarter, Yacktman�� biggest additions to his holdings were Research In Motion (RIMM) and Avon Products (AVP). He also surprised followers by venturing into financials, with new positions in Goldman Sachs (GS), Bank of America (BAC), State Street Corp. (STT) and Northern Trust Corp. (NTRS).

  • [By Tim Higgins]

    Harris Associates LP, State Street Corp. (STT) and Berkshire Hathaway Inc. (BRK/B) led purchases of General Motors Co. (GM) last quarter as the U.S. government continued selling shares and GM rejoined the Standard & Poor�� 500 Index.

Top 5 Companies To Buy Right Now: ANN Inc (ANN)

ANN INC., incorporated in 1988, through its wholly owned subsidiaries, is a specialty retailer of women�� apparel, shoes and accessories sold primarily under the Ann Taylor and LOFT brands. The Company�� Ann Taylor and LOFT brands offers a range of career and casual separates, dresses, tops, weekend wear, shoes and accessories. It offers updated past season sellers from the Ann Taylor and LOFT merchandise collections at its Ann Taylor Factory and LOFT Outlet stores, respectively, and the clients can also shop online at www.anntaylor.com and www.LOFT.com (together, Online Stores), or by phone at 1-800-DIAL-ANN and 1-888-LOFT-444. As of January 28, 2012, it operated 953 retail stores in 46 states, the District of Columbia and Puerto Rico, consisted of 280 Ann Taylor stores, 500 LOFT stores, 99 Ann Taylor Factory stores and 74 LOFT Outlet stores.

Substantially all of the Company�� merchandise is developed by its in-house product design and development teams, who design merchandise exclusively for the Company. A small percentage of its merchandise is purchased through branded vendors, which is selected to complement its in-house assortment. The Company sourced merchandise from approximately 138 manufacturers and vendors in 19 countries. Approximately 42% of its merchandise unit purchases originated in China, 13% in the Philippines, 14% in Indonesia, 14% in India, and 13% in Vietnam. The Company�� wholly owned subsidiary, AnnTaylor Distribution Services, Inc., owns its 256,000-square-foot distribution center located in Louisville, Kentucky. The distribution center is located on approximately 27 acres. Its merchandise is distributed to stores, including the Online Stores, through this facility.

An average Ann Taylor store is approximately 5,500 square feet in size. The Company operates two Ann Taylor flagship stores, one located in New York City and one located in Chicago. LOFT stores average approximately 5,800 square feet. The Company also operates one LOFT flagship store! on the ground floor of 7 Times Square, its corporate headquarters, in New York City. During the fiscal year ended January 28, 2012 (fiscal 2011), it opened 14 LOFT stores that averaged approximately 5,500 square feet. Ann Taylor Factory stores average approximately 7,100 square feet. LOFT Outlet stores average approximately 7,000 square feet. During fiscal 2011, its LOFT Outlet stores were 38 new stores that averaged approximately 7,600 square feet.

Top 5 Companies To Buy Right Now: Nuveen New York Select Quality Municipal Fund Inc.(NVN)

Nuveen New York Select Quality Municipal Fund, Inc. is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is managed by Nuveen Asset Management. It invests in the fixed income markets of New York. The fund invests in tax exempt municipal bonds. It employs fundamental analysis, with bottom-up stock picking approach, to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor?s New York Municipal Bond Index and Standard & Poor?s Insured National Municipal Bond Index. Nuveen New York Select Quality Municipal Fund, Inc. was formed on April 3, 1991 and is domiciled in the United States.

Thursday, September 26, 2013

Best Biotech Stocks To Watch For 2014

The Food and Drug Administration (FDA) made a groundbreaking policy change last year that is having a large impact on the biotech industry and creating a big opportunity for investors.

To create a faster path to commercialization for potentially life-saving drugs and medicine, the FDA in July introduced a new "breakthrough" status for drugs that show "substantial improvement on existing therapies for clinically significant endpoints."

 

For an industry that is accustomed to a costly 10-year commercialization process, the breakthrough status is a welcome shift. An accelerated channel to commercialization could enable drug companies to shave years and billions of dollars from the cumbersome process.

Best Biotech Stocks To Watch For 2014: Nektar Therapeutics(NKTR)

Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. The company?s product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology. Its research and development activities involve small molecule drugs, peptides, and other potential biologic drug candidates. The company?s proprietary drug candidates in clinical development comprise NKTR-118, a peripheral opioid antagonist, which has completed Phase II clinical trail for the treatment of opioid-induced constipation; BAY41-6551 that has completed Phase II clinical trail to treat gram-negative pneumonias; NKTR-102, a topoisomerase I inhibitor-polymer conjugate, which is in Phase II clinical trail for multiple cancer indications, including breast, ovarian, and colorectal; and NKTR-105 that is in Phase I clinica l trail to treat solid tumors. Its preclinical products consists of NKTR-119 (Opioid/NKTR-118 combinations) for the treatment of pain; NKTR-181 (abuse deterrent, tamper-resistant opioid) to treat pain; NKTR-194 (non-scheduled opioid) for the treatment of mild to moderate pain; NKTR-171 (tricyclic antidepressant) to treat neuropathic pain; and NKTR-140 (protease inhibitor candidate) to treat HIV. The company has collaboration with Bayer Healthcare LLC to develop BAY41-6551 (NKTR-061, Amikacin Inhale), which is an inhaled solution of amikacin, an aminoglycoside antibiotic; and a license agreement with AstraZeneca AB for the development and commercialization of Oral NKTR-118 and NKTR-119. In addition, Nektar Therapeutics has various license, manufacturing, and supply agreements for its technology with biotechnology and pharmaceutical companies, such as Affymax, Amgen, Baxter, Roche, Merck, Pfizer, and UCB Pharma. The company was founded in 1990 and is headquartered in San Franc isco, California.

Advisors' Opinion:
  • [By Jay Silverman]

    Steve Halpern: Another stock you follow closely is Nektar (NKTR). What do you see happening there?

    Jay Silverman: Yes, Nektar is another platform company at the MTSL and they are about to release data on one of their compounds that is a pain reliever-unlike the very severe side effects of OxyContin, the opioid pain relievers that are out there, which have caused severe health and addictive concerns, leading to very, very troublesome side effects and death in some cases.

Best Biotech Stocks To Watch For 2014: Cell Therapeutics Inc (CTIC)

Cell Therapeutics, Inc. (CTI), incorporated in 1991, develops, acquires and commercializes treatments for cancer. The Company�� research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer. As of December 31, 2011, CTI focused its efforts on Pixuvri (pixantrone dimaleate) (Pixuvri), OPAXIO (paclitaxel poliglumex) (OPAXIO), tosedostat, brostallicin and bisplatinates. As of December 31, 2011, it developed Pixuvri, an anthracycline derivative for the treatment of hematologic malignancies and solid tumors. Another late-stage drug candidate of the Company, OPAXIO, is being studied as a potential maintenance therapy for women with advanced stage ovarian cancer, who achieve a complete remission following first-line therapy with paclitaxel and carboplatin. As of December 31, 2011, it also developed tosedostat in collaboration with Chroma Therapeutics, Ltd. (Chroma). On May 31, 2012, CTI completed its acquisition gaining worldwide rights to S*BIO Pte Ltd.'s (S*BIO) pacritinib.

Pixuvri

As of December 31, 2011, the Company developed Pixuvri, an aza-anthracenedione derivative, for the treatment of non-Hodgkin�� lymphoma (NHL), and various other hematologic malignancies, and solid tumors. Pixuvri was studied in the Company�� EXTEND, or PIX301, clinical trial, which was a phase III single-agent trial of Pixuvri for patients with relapsed, refractory aggressive NHL who received two or more prior therapies and who were sensitive to treatment with anthracyclines. On September 28, 2011, CTI announced that a second independent radiology assessment of response and progression endpoint data from its PIX301 clinical trial of Pixuvri was achieved with statistical significance. The results of the EXTEND trial met its primary endpoint and showed that patients randomized to treatment with Pixuvri achieved a significantly higher rate of confirmed and unconfirmed complete response compared to patients treated with standard chem! otherapy had a significantly increased overall response rate and experienced a statistically significant improvement in median progression free survival. Pixuvri had predictable and manageable toxicities when administered at the proposed dose and schedule in the EXTEND clinical trial in heavily pre-treated patients. In March 2011, the Company initiated the PIX-R trial to study Pixuvri in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Pixuvri has also been studied in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens. In the second quarter of 2010, the NCCTG opened this phase II study for enrollment. The study is closed to accrual and results are expected to be reported by the NCCTG later in 2012.

OPAXIO

OPAXIO is the Company�� biologically-enhanced chemotherapeutic agent that links paclitaxel to a biodegradable polyglutamate polymer, resulting in a new chemical entity. As of December 31, 2011, the Company focused its development of OPAXIO on ovarian, brain, esophageal, head and neck cancer. OPAXIO was designed to improve the delivery of paclitaxel to tumor tissue while protecting normal tissue from toxic side effects. In November 2010, results were presented by the Brown University Oncology Group from a phase II trial of OPAXIO combined with temozolomide (TMZ), and radiotherapy in patients with newly-diagnosed, high-grade gliomas, a type of brain cancer. The trial demonstrated a high rate of complete and partial responses and a high rate of six month progression free survival (PFS). Based on these results, the Brown University Oncology Group has initiated a randomized, multicenter, phase II study of OPAXIO and standard radiotherapy versus TMZ and radiotherapy for newly diagnosed patients with glioblastoma with an active gene termed MGMT that reduces responsiveness to TMZ. A phase I/II study of OPAXIO combined with radi! otherapy ! and cisplatin was initiated by SUNY Upstate Medical University, in patients with locally advanced head and neck cancer.

Tosedostat

In March 2011, the Company entered into a co-development and license agreement with Chroma Therapeutics, Ltd. (Chroma), providing the Company with marketing and co-development rights to Chroma�� drug candidate, tosedostat, in North, Central and South America. Tosedostat is an oral, aminopeptidase inhibitor that has demonstrated anti-tumor responses in blood related cancers and solid tumors in phase I-II clinical trials. Interim results from the phase II OPAL study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML) showed that once-daily, oral doses of tosedostat had predictable and manageable toxicities and results demonstrated response rates, including a high-response rate among patients who received prior hypomethylating agents, which are used to treat myelodysplastic syndrome (MDS), a precursor of AML.

Brostallicin

As of December 31, 2011, the Company developed brostallicin through its wholly owned subsidiary, Systems Medicine LLC, which holds rights to use, develop, import and export brostallicin. Brostallicin is a synthetic deoxyribonucleic acid (DNA) minor groove binding agent that has demonstrated anti-tumor activity and a favorable safety profile in clinical trials, in which more than 230 patients have been treated as of December 31, 2011. The Company uses a genomic-based platform to guide the development of brostallicin. A phase II study of brostallicin in relapsed, refractory soft tissue sarcoma met its predefined activity and safety hurdles and resulted in a first-line phase II clinical trial study that was conducted by the European Organization for Research and Treatment of Cancer (EORTC).

The Company competes with Bristol-Myers Squibb Company, Sanofi-Aventis, Pfizer, Roche Group, Genentech, Inc., Astellas Pharma, Eli Lilly and Company, Celgene, Telik, I! nc., TEVA! Pharmaceuticals Industries Ltd. and PharmaMar.

Advisors' Opinion:
  • [By John Udovich]

    If you have not been watching the biotech sector lately, you should start paying attention as the sector along with small cap biotech stocks like Cell Therapeutics Inc (NASDAQ: CTIC), BIND Therapeutics Inc (NASDAQ: BIND) and TNI BioTech (OTCMKTS: TNIB) continue to produce a steady stream of good news for investors thanks to positive industry trends. Moreover, Ophthotech Corp (NASDAQ: OPHT), Foundation Medicine Inc (NASDAQ: FMI), Evoke Pharma and Fate Therapeutics Inc (NASDAQ: FATE) are this week's biotech IPOs that will no doubt be watched closely by Wall Street and industry observers in general. With that in mind, consider the following biotech news or recent articles about the industry and the small cap players in it:

  • [By Bryan Murphy]

    If you're reading this, then odds are you already know that the last two weeks (not even a full two weeks) have been more fruitful for Cell Therapeutics Inc. (NASDAQ:CTIC) shareholders than the prior two years have been - the stock's up 28% since last Thursday. And, odds are you already know why. The question most of you are asking now is, can CTIC actually keep climbing at this pace, or even keep climbing at any pace? The answer is "yes", though floating that answer almost inherently requires a deeper explanation.

Top 5 Growth Stocks To Own For 2014: Osiris Therapeutics Inc.(OSIR)

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat various medical conditions in the inflammatory, autoimmune, orthopedic, and cardiovascular areas. It operates in two business segments, Therapeutics and Biosurgery. The Therapeutics segment focuses on developing biologic stem cell drug candidates from a readily available and non-controversial source, adult bone marrow. The Biosurgery segment works to harness the ability of cells and novel constructs to promote the body's natural healing. This segment focuses on developing biologic products for use in surgical procedures. The company?s lead biologic drug candidate is Prochymal, which is in phase 2 and 3 clinical trails for various indications, including acute graft versus host disease (GvHD), Crohn's disease, acute myocardial infarction, type 1 diabetes, pulmonary disease, and gastrointestinal injury resulting from radiation exposure. Its biologic drug candidates also include Chondrogen, a preparation of adult mesenchymal stem cells that is in phase 2 clinical trials for osteoarthritis and cartilage protection. The company has collaboration agreements with Genzyme Corporation for the development and commercialization of Prochymal and Chondrogen in various countries except in the United States and Canada. It also has a partnership with Juvenile Diabetes Research Foundation for the development of Prochymal as a treatment for the preservation of insulin production in patients with newly diagnosed type 1 diabetes mellitus. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Advisors' Opinion:
  • [By Alexander Maxwell]

    One of the companies attempting to develop a better treatment for chronic diabetic foot ulcers is Osiris Therapeutics� (NASDAQ: OSIR  ) . Earlier this month, Osiris shares more than doubled as the company announced positive data for its CDFU drug Grafix. The study results were very impressive to say the least; the study was stopped early due to the overwhelming efficacy exhibited by the treatment. A main highlight is the fact that 62% of Grafix patients had their wound closed at 12 weeks, compared to only 21% of patients using conventional methods. Clearly, the efficacy in this endpoint was overwhelming. Grafix also achieved all of the secondary endpoints for the trial, and more importantly demonstrated a relatively benign safety record.�

Best Biotech Stocks To Watch For 2014: Cannabis Science Inc (CBIS.PK)

Cannabis Science, Inc., incorporated on May 4, 2007, is a development-stage company. The Company is engaged in the creation of cannabis-based medicines, both with and without psychoactive properties, to treats disease and the symptoms of disease, as well as for general health maintenance. On February 9, 2012, the Company acquired GGECO University, Inc. (GGECO). On March 21, 2012, the Company acquired Cannabis Consulting Inc. (CCI Group).

The Company is engaged in medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.

Best Biotech Stocks To Watch For 2014: Neurocrine Biosciences Inc.(NBIX)

Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company?s products in clinical development include Elagolix, a Phase II drug for endometriosis; Vesicular Monoamine Transporter 2 Inhibitor (VMAT2), a Phase II drug for movement disorders; CRF2 Peptide Agonist, a Phase II drug for cardiovascular diseases; CRF1 Antagonist, a Phase II drug for stress-related disorders; and Elagolix, a Phase II drug for uterine fibroids. Its research programs comprise G Protein-Coupled Receptor 119 (GPR119) for type II diabetes; VMAT2 for schizophrenia; GnRH Antagonists for men?s and women?s health, and oncology; Antiepileptic Drugs for epilepsy, essential tremor, and pain; and G Protein-Coupled Receptors for other conditions. The company has collaborations with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize Indiplon in Japan; Abbott International Luxembourg S.�r.l. to develop and commercialize elagolix and GnRH antagonists for women?s and men?s health indications; and Boehringer Ingelheim International GmbH to research, develop, and commercialize small molecule GPR119 agonists for the treatment of type II diabetes and other indications. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.

Stocks to Watch: Mako Surgical, Ascena, Oncothyreon

Among the companies with shares expected to actively trade in Wednesday’s session are Mako Surgical Corp.(MAKO), Ascena Retail Group Inc.(ASNA) and Oncothyreon Inc.(ONTY)

Stryker Corp.(SYK) agreed to acquire Mako Surgical for roughly $1.65 billion, a move that will provide the orthopedics product maker with access to Mako’s robotic assisted surgery platform. Mako shareholders will receive $30 a share, a 86% premium to Tuesday’s close. Shares surged 82% to $29.46 premarket.

Ascena’s fiscal fourth-quarter earnings surged on stronger sales and margins as well as lower acquisition-related charges. The women’s apparel retailer’s shares were up 14% at $19.80 premarket as adjusted earnings from continuing operations and revenue beat expectations.

Oncothyreon said Germany’s Merck KGaA(MRK.XE) has decided to continue clinical development of Oncothyreon’s lung cancer drug tecemotide, even though the drug didn’t meet its primary endpoint in a prior Phase 3 study. Merck Serono will conduct a new Phase 3 trial called START2 for patients with locally advanced Stage III nonsmall cell lung cancer. The small biotechnology company’s shares surged 22% to $2.20 in premarket trading.

Morgan Stanley(MS) downgraded Carnival Corp.(CCL) to underweight from equalweight, noting the cruise-line operator has underperformed peers in terms of yield performance for seven out of the past eight years. “The recovery could take longer than expected,” the firm said, adding costs are rising due to the fleet enhancement program, new fuel emission rules and higher marketing and distribution costs. Shares slipped 4.6% to $32.95 premarket.

Biotech company Clovis Oncology Inc.(CLVS), which was considering a sale, didn’t enter any deal talks and is no longer seeking bids, Bloomberg News reported, citing a person with knowledge of the matter. Shares dropped 14% to $63.51 premarket.

Chatham Lodging Trust(CLDT) unveiled a plan to offer at least 3.3 million shares, as the real-estate investment trust looks to raise proceeds to repay debt and help fund a portion of a property acquisition in Bellevue, Wash. Shares slipped 5.4% to $18.35 premarket.

Brocade Communications Systems Inc.(BRCD) raised its stock buyback program to $1 billion from $308 million, as the company cited confidence in generating greater cash flow as well as its long-term business prospects. Shares rose 3.8% premarket to $8.49.

AAR Corp.'s(AIR) fiscal first-quarter profit fell 1.6% as the aviation products and services supplier’s overall sales declined.

Bank-holding company Banner Corp.(BANR) on Tuesday said it had agreed to buy Home Federal Bancorp Inc.(HFBL) (HOME) for $197 million in cash and stock. The deal, expected to close in the first quarter of 2014, will result in a combined company with about $5.2 billion in assets, making it the fourth-largest bank in the Pacific Northwest by assets, the companies said.

Car auctioneer Copart Inc.'s(CPRT) reported a weaker-than-expected fiscal fourth-quarter profit because of higher expenses. While revenue growth topped analysts’ expectations, the bottom line surprisingly fell 8% from a year ago as Copart’s expenses–including yard operation and vehicle sale costs–jumped from the prior year.

Crown Holdings Inc.(CCK) cut its third-quarter earnings guidance on lower end-user demand in some of the food-and-beverage packaging company’s markets, including European food cans and North American beverage cans.

Health Management Associates Inc.(HMA) said its newly constituted board is evaluating its $3.9 billion deal to be acquired by fellow hospital operator Community Health Systems Inc.(CYH) The review comes about a month after hedge fund Glenview Capital Management LLC gained shareholder approval to replace the hospital operator’s entire board. But its agreement earlier this year to be acquired by rival Community Health didn’t appease Glenview, which also is the top shareholder in Community Health.

Landec Corp.'s(LNDC) fiscal first-quarter profit grew 8.8% as the food-packaging maker reported higher revenue due to strong demand for vegetables. Margins, however, fell due to an increase in lower-margin food service sales and higher-than-expected raw produce costs.

Offshore driller Noble Corp.(NE) disclosed a plan to split the company into two separate firms, potentially moving to file an initial public offering for a business that would own the company’s older rigs. Noble has been mulling a plan to shed some assets for a few years and even conceded the process to evaluate such a move was taking longer than expected.

Ntelos Holdings Corp.(NTLS) said it had settled disputes with Sprint Corp.(S) related to the companies’ strategic network alliance. The settlement resolves a dispute over the reset of data rates that began in the fourth quarter of 2011, as well as unrelated billing disputes raised in the third quarter of 2012. Shares of Ntelos were up 9.7% at $17.50 in after-hours trading.

Tuesday, September 24, 2013

U.S. Companies Should Raise Dividends -- Here's Why

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis.

We at The Motley Fool are long-term, fundamental investors. Unfortunately, this appears to be a minority view in the capital markets. As such, when I come across a professional investor who has something clever to say along these lines, I thinks it's worth highlighting. This week's Barron's interview with Daniel Peris of Federated Investors, titled "Time to Wake Up and Start Paying Dividends," falls in that category (a sign-up may be required).

Peris, who co-manages the Federated Strategic Value Dividend fund and has written two books on dividend investing, came to money management via a detour in academia -- he holds a Ph.D. in Soviet history. However, the lack of a finance degree hasn't stopped him from securing a proper understanding of stocks and investing (OK, he is a CFA charterholder):

We view our task as investing in businesses, not stocks. ... Our fundamental premise is that these are businesses, and we are taking a stake in them. And, oh, by the way, they just happen to be publicly traded. And, yes, it's fine that these businesses reprice every day in the stock market. But the fact that our holdings are publicly traded is, for us, a matter of convenience. It is not the goal, fundamentally, to buy low, sell high, and repeat frequently. For us, the goal is to be a business owner.

A kindred spirit! Billionaire investor Warren Buffett wouldn't have put it any differently. So how do dividends fit into that picture?

If you are going to be a minority owner of a publicly traded business, your compensation for putting up that capital, and for becoming a business owner, is in the form of the dividend. So we look at the dividend and the dividend's growth.

In fact, dividends are a vital component of value and, consequently, stock returns:

In its most simplified form, only a few key numbers are important, and it turns out that the dividend yield is really what drives the overall equation. Also part of that equation: What is the growth of the cash stream, and what is the discount rate? This could be in regard to an apartment building, an oil well, a chain of dry cleaners, or a publicly traded company. What's the cash stream versus the purchase price and/or the yield? So we try to quantify that.

The trouble is, when Peris applies that logic to the broad market, the numbers don't add up:

The problem with the S&P 500 (SNPINDEX: ^GSPC  )   -- that is, the major part of the U.S. stock market, large publicly traded corporations -- is that if you are going to be honest and put in a 5% or 6% dividend-growth rate, but you have only a 2% yield, you have to use an abnormally low discount rate in order to have a present value that is positive. Or you can use a normal discount rate. But then you have to use an abnormally high growth rate. The Gordon Growth Model [which values a stock based on a series of future cash flows that are discounted] is a gross simplification with flaws. But it's a good rule of thumb. And it makes you think about being realistic and whether you are understating risk or whether you are overstating your expectations for what these large corporations are going to be doing.

In other words, at a 2% dividend yield, the broad market is overvalued and the prospects for long-term stock returns are, thus, uninspiring. One way in which U.S. companies could alter the dynamics of that equation is to reduce share buybacks in favor of higher dividend payouts. Indeed, the S&P 500's trailing-12-month dividend payout ratio, which tracks the proportion of earnings paid out to shareholders via dividends, is very low by historical standards.

With a higher dividend yield, the numbers stack up a lot more favorably -- or, as Peris puts it: "[O]ur portfolios have a gross yield of 4.5% to 5%. With that kind of a yield, I can make that present-value calculation work a lot more easily than I can when the starting yield is 2%."

According to Barron's, Peris is reluctant to discuss individual stocks, but the top three holdings in his fund, as of July 31, were Dow Jones (DJINDICES: ^DJI  ) component AT&T, ConocoPhillips, and Kraft Foods.

If you're looking for some long-term investing ideas, you're invited to check out The Motley Fool's brand-new special report, "The 3 Dow Stocks Dividend Investors Need." It's absolutely free, so simply click here now and get your copy today.

Monday, September 23, 2013

Inherited IRA's Could See Changes With Obama Budget

In his latest budget that was submitted to Congress, President Obama included 6 changes involving Individual Retirement Accounts (IRA’s), including Inherited IRA’s. So, why are Inherited IRA’s important? And how might these changes affect retirees?

Inherited IRAs (sometimes referred to as “stretch IRAs”) have been a wonderful way to pass on wealth to the next generation while preserving the tax-deferred compounded growth that is the main benefit associated with the traditional IRA.

There isn’t any way to know if this, or the other proposed changes, will become law, but it is worth being aware so we can be prepared. Today, I decided to focus on Inherited IRA’s because of the impact any changes may have on retirees and their children.

For instance, Sam has added money to his 401k plan throughout his 30-year career. Combined with the company match, he accumulated $1.5 million dollars by the time he retired at age 60. Sam rolled that money to an Individual Retirement Account and it continued to grow, even after he started taking required minimum distributions when he turned 70 ½.

Knowing that his wife would be taken care of in the event of his death, he names his 3 children as the primary beneficiaries of his IRA. Under current law, when he dies, each child has the option of only taking out the required amount based on their life expectancy. The rest can remain in the IRA and continue to grow tax-deferred. Assuming that the Sam’s child was 40 when he/she inherited the IRA, he/she could have another 30 years or more of tax-deferred growth.

Think about that: Sam deferred the taxes on his contributions to his 401k, taxes on the company match and the taxes on that growth for over 45 years assuming he dies at age 75. Then the 40-year old child can continue that deferral for another 30-40 years, but will have to take out required distributions each year. All told, it is possible for there to have been almost 80 years of tax-deferred growth!

With all the budget deficits and the current administration’s concept of Robin Hood ‘fairness’, it is easy to see why the government would want to find a way to get their taxes on the money in the IRA more quickly. Frankly, I can’t blame them—80 years is a long time to wait! Thus, they are focusing on Inherited IRA’s.

In the current budget that the Obama administration submitted, those inheriting an IRA would be required to drain the account by the end of the fifth year after the original owner’s death. That still leaves almost 50 years of tax-deferred growth in the example above—not bad.

If this becomes law, many retirees will want to revisit their beneficiary strategies to see if it might be worth making some changes and/or adjustments. And it is likely that this will not become law—Senator Max Baucus has tried to get this type of measure passed but hasn’t been successful. Still, it is worth keeping an eye on it and even contacting your Congressional members to let them know if you oppose it.

Common Sense Advisors does not offer investment advice via this medium. Under no circumstance whatsoever do these postings, opinions, charts, or any other information represent a recommendation or personalized investment, tax, or financial planning advice. Learn more about our firm at www.commonsenseadvisors.com

Twitter:  @JeffVoudrie

Any opinions expressed herein are solely those of the author and do not in any way represent the views or opinions of any other person or entity.

The post Inherited IRA's Could See Changes With Obama Budget by Jeff Voudrie appeared first on See It Market.

The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Sunday, September 22, 2013

Top 10 Undervalued Stocks To Watch For 2014

Key Points:
Global dividend payers are undervalued relative to U.S. counterparts
Valuations indicate the dividend trade has room to run��lobally
In rising rate environments:
U.S. dividends historically underperform
U.S. shareholder yield historically outperforms
Global dividends historically outperform
A focus on valuation and yield currently favors investments in Europe, Emerging Markets, global Telecom, and EnergyThe S&P 500 Index has risen over 150 percent since March 9, 2009 in what could arguably be deemed the most hated equity rally of all time. The MSCI All Country World Index, one of the broadest global indices, has risen ��ust��110 percent since its March 2009 nadir. Evidence indicates that United States (U.S.) investors have not participated in this rally�� truly sad state of affairs.1 It is worthy of noting that over the last several years a number of well known market pundits have viscerally rejected the equity rally due to macroeconomic concerns. The reality, however, is that stock returns are more highly correlated with the price you pay than macroeconomic events. The one place U.S. investors seem to have nibbled as they tip-toe back into the equity market is in U.S. dividend paying equities.

Top 10 Undervalued Stocks To Watch For 2014: Schlumberger N.V.(SLB)

Schlumberger Limited, together with its subsidiaries, supplies technology, integrated project management, and information solutions to the oil and gas exploration and production industries worldwide. The company?s Oilfield Services segment provides exploration and production services; wireline technology that offers open-hole and cased-hole services; supplies engineering support, directional-drilling, measurement-while-drilling, and logging-while-drilling services; and testing services. This segment also offers well services; supplies well completion services and equipment; artificial lift; data and consulting services; geo services; and information solutions, such as consulting, software, information management system, and IT infrastructure services that support oil and gas industry. Its WesternGeco segment provides reservoir imaging, monitoring, and development services; and operates data processing centers and multiclient seismic library. This segment also offers variou s services include 3D and time-lapse (4D) seismic surveys to multi-component surveys for delineating prospects and reservoir management. The company?s M-I SWACO segment supplies drilling fluid systems to improve drilling performance; fluid systems and specialty tools to optimize wellbore productivity; production technology solutions to maximize production rates; and environmental solutions that manages waste volumes generated in drilling and production operations. Its Smith Oilfield segment designs, manufactures, and markets drill bits and borehole enlargement tools; and supplies drilling tools and services, tubular, completion services, and other related downhole solutions. The company?s Distribution segment markets pipes, valves, and fittings, as well as mill, safety, and other maintenance products. This segment also provides warehouse management, vendor integration, and inventory management services. Schlumberger Limited was founded in 1927 and is based in Houston, Texas.

Advisors' Opinion:
  • [By Jonas Elmerraji]

    2013 has been a stellar year for shares of oil service giant Schlumberger (SLB). Since the calendar flipped over to January, SLB has rallied more than 25%, beating the broad market's impressive pace by double digits. As oil prices linger on the high end of their historic range, SLB is well positioned to keep ticking higher.

    Schlumberger provides must-have services to national and supermajor oil firms as well as smaller E&Ps, offering up niche services like seismic surveys and well drilling and positioning. In a nutshell, SLB's job is to pull oil out of the ground as efficiently as possible. Oil firms turn to Schlumberger because the tasks they need to accomplish are too nuanced or proprietary to pull off in-house. So as long as the company continues to pour cash into R&D for drilling technology and software, the firm should continue to score lucrative contracts.

    Some of Schlumberger's most attractive opportunities right now come from overseas. The firm is one of the largest oil servicers in Russia, a key growth market in the years ahead. It's also got an important presence in smaller oil markets, where it's a big fish in a small pond. A big scale and stellar reputation should guarantee Schlumberger an attractive piece of the oil pie for years to come.

  • [By Tony Daltorio]

    The biggest oilfield service companies should get a big lift from the boom, Moors said. That includes Schlumberger Ltd. (NYSE: SLB), Halliburton Co. (NYSE: HAL), Weatherford International Ltd. (NYSE: WFT), and Baker Hughes Inc. (NYSE: BHI).

Top 10 Undervalued Stocks To Watch For 2014: Dollar Tree Inc.(DLTR)

Dollar Tree, Inc. operates discount variety stores in the United States and Canada. Its stores offer merchandise primarily at the fixed price of $1.00. The company operates its stores under the names of Dollar Tree, Deal$, Dollar Tree Deal$, Dollar Giant, and Dollar Bills. Its stores offer consumable merchandise, including candy and food, and health and beauty care, as well as household consumables, such as paper, plastics, household chemicals, in select stores, and frozen and refrigerated food; variety merchandise, which includes toys, durable housewares, gifts, party goods, greeting cards, softlines, and other items; and seasonal goods, such as Easter, Halloween, and Christmas merchandise. As of April 30, 2011, it operated 4,089 stores in 48 states and the District of Columbia, as well as 88 stores in Canada. The company was founded in 1986 and is based in Chesapeake, Virginia.

Advisors' Opinion:
  • [By Lawrence Meyers]

    As a convenience store, it doesn’t have direct competition from�Dollar Tree (DLTR) or Family Dollar (FDO) because these dollar stores aren�� exclusively focused on food (and they have no gasoline or cigarette sales), and they��e targeted at the folks who are trying to save money over convenience, not vice versa. The convenience angle is another reason why�Walmart (WMT) and Costco (COST)�aren’t competitors, since those behemoths are about a total shopping experience.

Top 5 Companies To Invest In 2014: Caterpillar Inc.(CAT)

Caterpillar Inc. manufactures and sells construction and mining equipment, diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives worldwide. It operates through three lines of businesses: Machinery, Engines, and Financial Products. The Machinery business offers construction, mining, and forestry machinery, including track and wheel tractors, track and wheel loaders, pipelayers, motor graders, wheel tractor-scrapers, track and wheel excavators, backhoe loaders, log skidders, log loaders, off-highway trucks, articulated trucks, paving products, skid steer loaders, underground mining equipment, tunnel boring equipment, and related parts. It also manufactures diesel-electric locomotives; and manufactures and services rail-related products and logistics services for other companies. The Engines business provides diesel, heavy fuel, and natural gas reciprocating engines for Caterpillar machinery, electric power generation systems, marine, petrol eum, construction, industrial, agricultural, and other applications. It offers industrial turbines and turbine-related services for oil and gas, and power generation applications. This business also remanufactures Caterpillar engines, machines, and engine components; and offers remanufacturing services for other companies. The Financial Products business provides retail and wholesale financing alternatives for Caterpillar machinery and engines, solar gas turbines, and other equipment and marine vessels, as well as offers loans and various forms of insurance to customers and dealers. It also offers financing for vehicles, power generation facilities, and marine vessels. The company markets its products directly, as well as through its distribution centers, dealers, and distributors. It was formerly known as Caterpillar Tractor Co. and changed its name to Caterpillar Inc. in 1986. Caterpillar Inc. was founded in 1925 and is headquartered in Peoria, Illinois.

Advisors' Opinion:
  • [By Shauna O'Brien]

    Bank of America/Merrill Lynch reported on Tuesday that it has cut its estimates on Caterpillar Inc. (CAT).

    The firm, which currently has a “Neutral” rating on CAT, has lowered estimates on the company through 2015. Analysts currently have a $88 price target on CAT, suggesting a 1% increase from the stock’s current price of $86.88.

    Caterpillar shares were mostly flat during Tuesday morning trading. The stock has been mostly flat YTD.

  • [By Rebecca McClay]

    Building roads and bridges takes a lot of heavy equipment, and that's exactly what Caterpillar (CAT) makes. Whether a project needs backhoes, excavators, pavers or the articulated trucks to get asphalt and other building materials from one location to another, the Peoria, Ill., manufacturer is the industry leader both in the U.S. and abroad.

Top 10 Undervalued Stocks To Watch For 2014: Tupperware Corporation(TUP)

Tupperware Brands Corporation operates as a direct seller of various products across a range of brands and categories through an independent sales force. The company engages in the manufacture and sale of kitchen and home products, and beauty and personal care products. It offers preparation, storage, and serving solutions for the kitchen and home, as well as kitchen cookware and tools, children?s educational toys, microwave products, and gifts under the Tupperware brand name primarily in Europe, Africa, the Middle East, the Asia Pacific, and North America. The company provides beauty and personal care products, which include skin care products, cosmetics, bath and body care, toiletries, fragrances, nutritional products, apparel, and related products principally in Mexico, South Africa, the Philippines, Australia, and Uruguay. It offers beauty and personal care products under the Armand Dupree, Avroy Shlain, BeautiControl, Fuller, NaturCare, Nutrimetics, Nuvo, and Swissgar de brand names. The company sells its Tupperware products directly to distributors, directors, managers, and dealers; and beauty products primarily through consultants and directors. As of December 26, 2009, the Tupperware distribution system had approximately 1,800 distributors, 61,300 managers, and 1.3 million dealers; and the sales force representing the Beauty businesses approximately 1.1 million. The company was formerly known as Tupperware Corporation and changed its name to Tupperware Brands Corporation in December 2005. The company was founded in 1996 and is headquartered in Orlando, Florida.

Wednesday, September 18, 2013

In Budget Faceoff, Obama Warns of 'Economic Chaos'

AP, Pablo Martinez Monsivais WASHINGTON -- A potential federal shutdown looming, President Barack Obama on Monday warned congressional Republicans they could trigger national "economic chaos" if they demand a delay of his health care law as the price for supporting continued spending for federal operations. House Republican leaders were to meet Tuesday in hopes of finding a formula that would avoid a shutdown on Oct. 1 without alienating party conservatives who insist on votes to undercut the Affordable Care Act. Even more daunting is a mid- to late-October deadline for raising the nation's borrowing limit, which some Republicans also want to use as leverage against the Obama administration. "Are some of these folks really so beholden to one extreme wing of their party that they're willing to tank the entire economy just because they can't get their way on this issue?" Obama said in a speech at the White House. "Are they really willing to hurt people just to score political points?" The Republicans don't see it that way. House Speaker John Boehner, who opposes the threat of a shutdown, said, "It's a shame that the president could not manage to rise above partisanship today." Obama, said Boehner, "should be working in a bipartisan way to address America's spending problem, the way presidents of both parties have done before," and should delay implementation of the health care law. While some conservatives supported by the tea party have been making shutdown threats, Sen. Rand Paul of Kentucky said Monday that was "a dumb idea." At a community meeting in Louisville, he said, "We should fight for what we believe in and then maybe we find something in between the two. ... I am for the debate, I am for fighting. I don't want to shut the government down, though. I think that's a bad solution." Obama timed his remarks for the fifth anniversary of the bankruptcy of Wall Street giant Lehman Brothers, a major early event in the near-meltdown of the U.S. financial system and a severe global recession that preceded his presidency. He used the occasion to draw attention to the still-recovering economy and to what he called a "safer" financial system now in place. He delayed his remarks as authorities responded to the shootings that officials said left at least 13 people dead at the Washington Navy Yard just a few miles from the White House. While unemployment has dropped to 7.3 percent from a high of 10 percent and the housing market has begun to recover, the share of long-term unemployed workers is double what it was before the recession, and a homebuilding revival has yet to take hold. A new analysis conducted for The Associated Press shows that the gap in employment rates between America's highest- and lowest-income families has stretched to its widest level since officials began tracking the data a decade ago. Obama conceded the problems. "As any middle class family will tell you or anybody who's striving to get in the middle class, we are not yet where we need to be," he said. Still, his National Economic Council argued his case for progress, issuing a report detailing policies that it said had helped return the nation to a path toward growth. Those steps ranged from the unpopular Troubled Asset Relief Program, or TARP, that shored up the financial industry and bailed out auto giants General Motors and Chrysler, to an $800 billion stimulus bill and sweeping new bank regulations. Of the $245 billion that the government injected into the banking system, virtually all of it has been paid back, the report noted. "After all the progress that we've made over these last four and a half years, the idea of reversing that progress because of an unwillingness to compromise or because of some ideological agenda is the height of irresponsibility," Obama said. He reiterated his stance that he will not negotiate over the debt ceiling. Failure to raise it could lead to the first national default in U.S. history. Conservative Republicans, on the other hand, say the health care law, which has yet to take full effect, will place a burden on businesses and the public and will damage the economy. As a result, they insist that it be starved of taxpayer money or at least delayed. Chances are fading for a complicated GOP leadership plan that would allow the House to also vote to "defund Obamacare" but automatically separate the measures when delivering them to the Senate to ease the way for quick passage of a "clean" funding measure for delivery to Obama. The next steps aren't clear, but one option under consideration is to accede to conservatives' demands to deliver to the Democratic Senate a combined bill that pays for government and defunds the health care law. The Senate would be virtually certain to strip away the attack on the health care law and bounce the funding measure right back to the House. That scenario might frustrate conservatives, with the funding measure probably gaining enough votes to win passage in the House and proceed to the White House for Obama's signature. Stopgap spending bills are usually routine, so the difficult path for the current one hardly inspires confidence for an even more important measure to raise the government's borrowing cap. Republicans want to use the debt limit measure as a mechanism to win further spending cuts on top of those they forced upon Obama two years ago. It's not clear how the debt limit conundrum will be solved, though a time-tested recipe would be to add mostly symbolic reforms like a "no budget, no pay" proposal that worked early this year when House leaders orchestrated a debt limit increase that was intended to last through July or so but is now likely to suffice until mid-late October. The idea was that lawmakers wouldn't get paid if the chamber in which they served didn't pass a budget. It was a House GOP jab aimed at the Senate, which hadn't passed a budget since 2009. This year it did but there's been no effort to reconcile it with a competing House measure. Obama intends to continue pressuring Congress with daily events this week, including a speech Wednesday to the Business Roundtable, an association of CEOs from the top U.S. companies, and a trip Friday to Kansas City to visit a Ford plant, where he will promote the strength of the auto industry.

Tuesday, September 17, 2013

Triple Witching Hour

Double, double, toil and trouble, fire burn, and cauldron bubble. (the three witches chanting)
Macbeth, Act 4, Scene 1

Triple witching hour refers to the quarterly expiration of index futures, index future options and stock options on the third Friday of March, June, September and December.  This can, and often does, make for some chaotic trading as the large trading houses and hedge funds either close out their inter-related positions or roll them over to the next month. It is less messy than it used to be as the closing out is spread over the entire week and not done all on Friday as in years past. Still, it can make for some violent price swings this week. While not of much concern to the long term investor, the active trader needs to be extra cautious. This is why I recommend that all but the most experienced options traders unwind their positions by Thursday before expiration at the latest.

Combine this with the (soon to be outgoing) Fed chair speaking on Wednesday and the elections in Germany this Sunday and we have all the ingredients for a very volatile market.

Which is why it surprises me that the implied volatility indicator, VIX, is just around 14. That seems low to me given all the uncertainty as the market retests new highs. Hey, in June it was well over 20.

This tells me two things: One, buying a potential move in the stock market (straddles, strangles, etc) is a cheap speculative trade. And, two, if you want to hang on to your stock portfolio even as we're at sky high levels you can buy relatively cheap downside protection in the form of out of the money puts.

Actually, there's a third thing: Being net short option premium at these low levels with the three witches stirring the pot is a bad risk vs reward trade.

 

The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Saturday, September 14, 2013

Is Adobe a Buy?

With shares of Adobe (NASDAQ:ADBE) trading around $45, is ADBE an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let's analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Adobe operates as a diversified software company worldwide. It offers a line of software and services used by creative professionals, marketers, knowledge workers, application developers, enterprises, and consumers. Adobe markets and licenses its software directly to enterprise customers through its sales force and to end users through application stores and its website at www.adobe.com. Software products and platforms are seeing an increased adoption rate worldwide by consumers and businesses who are seeing increased technology exposure. The efficiency and ease offered by Adobe products make it a viable option to many. Look for Adobe to see rising profits as their products make their way into homes and businesses around the world.

T = Technicals on the Stock Chart are Strong

Adobe stock has been in a consolidation over the last several years but may be getting ready to soar higher. The stock is currently trading near the top-end of a multi-year range so a breakout higher may be imminent. Earnings for the company are approaching so a positive report may be the catalyst the stock needs to head higher. Analyzing the price trend and its strength can be done using key simple moving averages. What are the key moving averages? The 50-day (pink), 100-day (blue), and 200-day (yellow) simple moving averages. As seen in the daily price chart below, Adobe is trading above its rising key averages which signal neutral to bullish price action in the near-term.

ADBE

(Source: Thinkorswim)

Taking a look at the implied volatility (red) and implied volatility skew levels of Adobe options may help determine if investors are bullish, neutral, or bearish.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

Implied Volatility (IV)

30-Day IV Percentile

90-Day IV Percentile

Adobe Options

27.35%

90%

88%

What does this mean? This means that investors or traders are buying a very significant amount of call and put options contracts, as compared to the last 30 and 90 trading days.

Put IV Skew

Call IV Skew

June Options

Flat

Average

July Options

Flat

Average

As of today, there is an average demand from call buyers or sellers and low demand by put buyers or high demand by put sellers, all neutral to bullish over the next two months. To summarize, investors are buying a very significant amount of call and put option contracts and are leaning neutral to bullish over the next two months.

On the next page, let’s take a look at the earnings and revenue growth rates and the conclusion.

E = Earnings Are Increasing Quarter-Over-Quarter

Rising stock prices are often strongly correlated with rising earnings and revenue growth rates. Also, the last four quarterly earnings announcement reactions help gauge investor sentiment on Adobe’s stock. What do the last four quarterly earnings and revenue growth (Y-O-Y) figures for Adobe look like and more importantly, how did the markets like these numbers?

2012 Q4

2012 Q3

2012 Q2

2012 Q1

Earnings Growth (Y-O-Y)

-64.86%

26.03%

2.56%

0%

Revenue Growth (Y-O-Y)

-3.57%

0.11%

6.65%

Top Dividend Companies To Buy For 2014

9.90%

Earnings Reaction

4.19%

5.71%

4.25%

-2.73%

Adobe has seen increasing earnings and revenue figures over most of the last four quarters. From these figures, the markets have been excited about Adobe’s recent earnings announcements.

P = Excellent Relative Performance Versus Peers and Sector

How has Adobe stock done relative to its peers, Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Oracle (NASDAQ:ORCL), and sector?

Adobe

Apple

Microsoft

Oracle

Sector

Year-to-Date Return

21.05%

-13.81%

24.71%

-0.21%

10.41%

Adobe has been a relative performance leader, year-to-date.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

Conclusion

Adobe provides valuable software products to a wide range of consumers and businesses operating in diverse countries and industries around the world. The stock has been a strong performer in recent years and may be setting-up to head higher. Earnings and revenue figures have been mostly increasing in recent quarters which has kept investors satisfied. Relative to its peers and sector, Adobe has been a year-to-date performance leader. Look for Adobe to OUTPERFORM.

Friday, September 13, 2013

How Will Coca-Cola Stock Act After Latest Earnings?

With shares of Coca-Cola (NYSE:KO) trading around $40, is KO an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let's analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Coca-Cola is a beverage company that engages in the manufacture, marketing, and sale of nonalcoholic beverages worldwide. Its sparkling beverages include carbonated energy drinks, carbonated waters, and flavored waters. The company''s still beverages comprise nonalcoholic beverages, including noncarbonated waters, flavored and enhanced waters, noncarbonated energy drinks, juices and juice drinks, ready-to-drink teas and coffees, and sports drinks. Coca-Cola Company sells its products primarily under the Coca-Cola, Diet Coke, Coca-Cola Light, Coca-Cola Zero, Sprite, Fanta, Minute Maid, Powerade, Aquarius, Dasani, Glacéau Vitaminwater, Georgia, Simply, Del Valle, Ayataka, and I Lohas brand names.

Consumers around the world love the products offered by Coca-Cola, and enjoy them almost on a daily basis. Through its brands, Coca-Cola is able to reach a wide consumer base in just about every corner of the world. Those consumers will continue to enjoy its products for many years. On Tuesday morning, Coca-Cola reported disappointing second quarter earnings, blaming the drop on slow sales in Europe. The company has tried raising prices to cope, but economic troubles in Europe and Latin America are having a negative affect on Coca-Cola’s bottom line.

T = Technicals on the Stock Chart are Mixed

Coca-Cola stock has been exploding higher over the last several years. The stock is now trading at price levels not seen since 1998. Analyzing the price trend and its strength can be done using key simple moving averages.

What are the key moving averages? They are the 50-day (pink), 100-day (blue), and 200-day (yellow) simple moving averages. As seen in the daily price chart below, Coca-Cola is trading between its key averages, which signal neutral price action in the near-term.

KO

(Source: Thinkorswim)

Taking a look at the implied volatility (red) and implied volatility skew levels of Coca-Cola options may help determine if investors are bullish, neutral, or bearish.

Implied Volatility (IV)

30-Day IV Percentile

90-Day IV Percentile

Coca-Cola Options

17.83%

0%

0%

What does this mean? This means that investors or traders are buying a very small amount of call and put options contracts, compared to the last 30 and 90 trading days.

Put IV Skew

Call IV Skew

August Options

Flat

Average

September Options

Flat

Average

As of today, there is average demand from call buyers or sellers, and low demand by put buyers or high demand by put sellers, all neutral to bullish over the next two months. To summarize, investors are buying a very small amount of call and put option contracts, and are leaning neutral to bullish over the next two months.

On the next page, let’s take a look at the earnings and revenue growth rates, and what that means for Coca-Cola’s stock.

E = Earnings Are Mixed Quarter-Over-Quarter

Rising stock prices are often strongly correlated with rising earnings and revenue growth rates. The last four quarterly earnings announcement reactions can also help gauge investor sentiment on Coca-Cola’s stock. What do the last four quarterly earnings and revenue growth (Y-O-Y) figures for Coca-Cola look like, and more importantly, how did the markets like these numbers?

2013 Q2

2013 Q1

2012 Q4

2012 Q3

Earnings Growth (Y-O-Y)

3.28%

-12.36%

13.92%

4.17%

Revenue Growth (Y-O-Y)

-2.57%

-0.92%

3.76%

0.75%

Earnings Reaction

-1.41%*

5.68%

-2.71%

-0.60%

Coca-Cola has seen rising earnings and mixed revenue figures over the last four quarters. From these numbers, the markets have not been too happy with Coca-Cola’s recent earnings announcements.

* As of this writing

P = Weak Relative Performance Versus Peers and Sector

How has Coca-Cola stock done relative to its peers, Pepsi (NYSE:PEP), Dr. Pepper Snapple (NYSE:DPS), Monster Beverage (NASDAQ:MNST), and the overall sector?

Coca-Cola

Pepsi

Dr. Pepper Snapple

Monster Beverage

Sector

Year-to-Date Return

10.70%

22.75%

7.29%

14.97%

12.71%

Coca-Cola has been a poor relative performer, year-to-date.

Conclusion

Coca-Cola is an iconic company that provides beverage products through its recognized brands to consumers and companies in just about every country worldwide. But a recent slowdown in Latin American and European sales has negatively affected the company in the latest quarter.  The stock has been on a bullish run over the last several years, and is now trading at prices not seen since 1998. Over the last four quarters, earnings have been rising, while revenue figures have been mixed, which has resulted in disappointed reactions to the firm’s most recent earnings report. Relative to its peers and sector, Coca-Cola has been a weak year-to-date performer. WAIT AND SEE what Coca-Cola does this coming quarter.

Tuesday, September 10, 2013

Is Dish Network a Buy?

dish

With shares of Dish Network (NASDAQ:DISH) trading around $41, is it an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let's analyze the stock with the relevant sections of our Cheat Sheet investing framework:

T = Trends for a Stock’s Movement

Dish Network is a pay-television provider that offers a range of local and national programming, featuring more national and local high-definition channels than most pay-TV providers. A rising number of consumers are opting for satellite services due to the reduced costs and increased coverage offered. Dish Network is poised to capitalize on this rise in consumer interest as entertainment takes center stage for consumers in the United States. Most notably, the company has pulled away from a bidding war over Clearwire (NASDAQ:CLWR), which may prove positive. As a television giant, look for Dish Network to provide the services that consumers and companies love.

T = Technicals on the Stock Chart are Strong

Best China Stocks To Invest In 2014

Dish Network stock has been on a powerful move higher in the past few years. The stock is now trading near highs for the year and looks ready to continue upward. Analyzing the price trend and its strength can be done using key simple moving averages: 50-day (pink), 100-day (blue), and 200-day (yellow). As seen in the daily price chart below (source: Thinkorswim), Dish Network is trading above its rising key averages, which signals neutral to bullish price action in the near term.

DISH

Taking a look at the implied volatility and implied volatility skew levels of Dish Network options may help determine if investors are bullish, neutral, or bearish.

Implied Volatility (IV)

30-Day IV Percentile

90-Day IV Percentile

Dish Network Options

37.38%

3%

0%

What does this mean? This means that investors or traders are buying a small amount of call and put options contracts as compared to the past 30 and 90 trading days.

Put IV Skew

Call IV Skew

July Options

Flat

Average

August Options

Flat

Average

As of Thursday, there is average demand from call buyers or sellers and low demand by put buyers or high demand by put sellers, all neutral to bullish over the next two months. To summarize, investors are buying a very small amount of call and put option contracts, and are leaning neutral to bullish over the next two months.

 

E = Earnings Are Decreasing Quarter-Over-Quarter

Rising stock prices are often strongly correlated with rising earnings and revenue growth rates. The last four quarterly earnings announcement reactions also help gauge investor sentiment on Dish Network’s stock. What do the last four quarterly earnings and year-over-year revenue growth figures for Dish Network look like and, more importantly, how did the markets like these numbers?

2013 Q1

2012 Q4

2012 Q3

2012 Q2

Earnings Growth (Y-O-Y)

-41.25%

-34.09%

-149.30%

-33.33%

Revenue Growth (Y-O-Y)

-0.74%

-1.15%

-2.20%

-0.51%

Earnings Reaction

-2.04%

-0.16%

3.35%

-0.22%

Dish Network has seen decreasing earnings and revenue figures in the past four quarters. From these numbers, the markets have not been too pleased with Dish Network’s recent earnings announcements.

P = Excellent Relative Performance Versus Peers and Sector

How has Dish Network stock done relative to its peers – Directv (NYSE:DTV), Time Warner Cable (NYSE:TWC), Comcast (NASDAQ:CMCSA) — and sector?

Dish Network

Directv

Time Warner Cable

Comcast

Sector

Year-to-Date Return

13.52%

20.83%

9.21%

8.57%

11.49%

Dish Network has been a relative performance leader, year-to-date.

Conclusion

Dish Network provides in-demand national and local programming to consumers across the U.S. The stock has been on a powerful move higher and is now trading near highs for the year. In the past four quarters, investors in the company have not been too pleased, as earnings and revenue figures have been declining. Relative to its peers and sector, Dish Network has been a year-to-date performance leader. Look for Dish Network to OUTPERFORM.